|
MechanismmiR-21 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismMicroRNAs modulators |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Microlin Bio, Inc.
0 Patents (Medical) associated with Microlin Bio, Inc.
100 Deals associated with Microlin Bio, Inc.
100 Translational Medicine associated with Microlin Bio, Inc.